Literature DB >> 29741792

Frontline Science: Pathological conditioning of human neutrophils recruited to the airway milieu in cystic fibrosis.

Osric A Forrest1,2, Sarah A Ingersoll1,2, Marcela K Preininger1,2, Julie Laval1,2, Dominique H Limoli1,2, Milton R Brown1,2, Frances E Lee3, Brahmchetna Bedi4, Ruxana T Sadikot3,4, Joanna B Goldberg1,2, Vin Tangpricha3,4, Amit Gaggar5,6, Rabindra Tirouvanziam1,2.   

Abstract

Recruitment of neutrophils to the airways, and their pathological conditioning therein, drive tissue damage and coincide with the loss of lung function in patients with cystic fibrosis (CF). So far, these key processes have not been adequately recapitulated in models, hampering drug development. Here, we hypothesized that the migration of naïve blood neutrophils into CF airway fluid in vitro would induce similar functional adaptation to that observed in vivo, and provide a model to identify new therapies. We used multiple platforms (flow cytometry, bacteria-killing, and metabolic assays) to characterize functional properties of blood neutrophils recruited in a transepithelial migration model using airway milieu from CF subjects as an apical chemoattractant. Similarly to neutrophils recruited to CF airways in vivo, neutrophils migrated into CF airway milieu in vitro display depressed phagocytic receptor expression and bacterial killing, but enhanced granule release, immunoregulatory function (arginase-1 activation), and metabolic activities, including high Glut1 expression, glycolysis, and oxidant production. We also identify enhanced pinocytic activity as a novel feature of these cells. In vitro treatment with the leukotriene pathway inhibitor acebilustat reduces the number of transmigrating neutrophils, while the metabolic modulator metformin decreases metabolism and oxidant production, but fails to restore bacterial killing. Interestingly, we describe similar pathological conditioning of neutrophils in other inflammatory airway diseases. We successfully tested the hypothesis that recruitment of neutrophils into airway milieu from patients with CF in vitro induces similar pathological conditioning to that observed in vivo, opening new avenues for targeted therapeutic intervention. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  AMPK; energy metabolism; exocytosis; inflammation; phagocytes

Mesh:

Substances:

Year:  2018        PMID: 29741792      PMCID: PMC6956843          DOI: 10.1002/JLB.5HI1117-454RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  39 in total

1.  Neutrophils in chronic inflammatory airway diseases: can we target them and how?

Authors:  Y Gernez; R Tirouvanziam; P Chanez
Journal:  Eur Respir J       Date:  2010-03       Impact factor: 16.671

Review 2.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

3.  Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1.

Authors:  Sarah A Ingersoll; Julie Laval; Osric A Forrest; Marcela Preininger; Milton R Brown; Dalia Arafat; Greg Gibson; Vin Tangpricha; Rabindra Tirouvanziam
Journal:  J Immunol       Date:  2015-04-29       Impact factor: 5.422

4.  Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine.GlyR alpha 2/TRPM2/p38 MAPK signaling.

Authors:  Chang-Won Hong; Taek-Keun Kim; Hwa-Yong Ham; Ju-Suk Nam; Yong Ho Kim; Haifeng Zheng; Bo Pang; Tae-Kwon Min; Jun-Sub Jung; Si-Nae Lee; Hyun-Jeong Cho; Ee-Jin Kim; In-Hwan Hong; Tae-Cheon Kang; Jongho Lee; Seog Bae Oh; Sung Jun Jung; Sung Joon Kim; Dong-Keun Song
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

5.  CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis.

Authors:  Richard G Painter; Vincent G Valentine; Nicholas A Lanson; Kevin Leidal; Qiang Zhang; Gisele Lombard; Connie Thompson; Anand Viswanathan; William M Nauseef; Guangdi Wang; Guoshun Wang
Journal:  Biochemistry       Date:  2006-08-29       Impact factor: 3.162

6.  Metformin induces suppression of NAD(P)H oxidase activity in podocytes.

Authors:  Agnieszka Piwkowska; Dorota Rogacka; Maciej Jankowski; Marek Henryk Dominiczak; Jan Kazimierz Stepiński; Stefan Angielski
Journal:  Biochem Biophys Res Commun       Date:  2010-02-01       Impact factor: 3.575

7.  Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.

Authors:  Rabindra Tirouvanziam; Yael Gernez; Carol K Conrad; Richard B Moss; Iris Schrijver; Colleen E Dunn; Zoe A Davies; Leonore A Herzenberg; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

8.  Primary inflammation in human cystic fibrosis small airways.

Authors:  Rabindra Tirouvanziam; Ibrahim Khazaal; Bruno Péault
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

9.  Metabolic adaptation of neutrophils in cystic fibrosis airways involves distinct shifts in nutrient transporter expression.

Authors:  Julie Laval; Jawida Touhami; Leonore A Herzenberg; Carol Conrad; Naomi Taylor; Jean-Luc Battini; Marc Sitbon; Rabindra Tirouvanziam
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

10.  Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.

Authors:  Carla Maria P Ribeiro; Harry Hurd; Yichao Wu; Mary E B Martino; Lisa Jones; Brian Brighton; Richard C Boucher; Wanda K O'Neal
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

View more
  29 in total

1.  Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.

Authors:  Jonas C Schupp; Sara Khanal; Jose L Gomez; Maor Sauler; Taylor S Adams; Geoffrey L Chupp; Xiting Yan; Sergio Poli; Yujiao Zhao; Ruth R Montgomery; Ivan O Rosas; Charles S Dela Cruz; Emanuela M Bruscia; Marie E Egan; Naftali Kaminski; Clemente J Britto
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

Review 2.  Older but Not Wiser: the Age-Driven Changes in Neutrophil Responses during Pulmonary Infections.

Authors:  Shaunna R Simmons; Manmeet Bhalla; Sydney E Herring; Essi Y I Tchalla; Elsa N Bou Ghanem
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

3.  Neutrophil-targeted, protease-activated pulmonary drug delivery blocks airway and systemic inflammation.

Authors:  Joscelyn C Mejías; Osric A Forrest; Camilla Margaroli; David A Frey Rubio; Liliana Viera; Jindong Li; Xin Xu; Amit Gaggar; Rabindra Tirouvanziam; Krishnendu Roy
Journal:  JCI Insight       Date:  2019-12-05

Review 4.  Our evolving view of neutrophils in defining the pathology of chronic lung disease.

Authors:  Kyle T Mincham; Nicoletta Bruno; Aran Singanayagam; Robert J Snelgrove
Journal:  Immunology       Date:  2021-10-04       Impact factor: 7.215

5.  Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds.

Authors:  Aurélie Moniot; Julien Braux; Renaud Siboni; Christine Guillaume; Sandra Audonnet; Ingrid Allart-Simon; Janos Sapi; Rabindra Tirouvanziam; Stéphane Gérard; Sophie C Gangloff; Frédéric Velard
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

6.  Neutrophil dysfunction in cystic fibrosis.

Authors:  Lael M Yonker; Anika Marand; Sinan Muldur; Alex Hopke; Hui Min Leung; Denis De La Flor; Grace Park; Hanna Pinsky; Lauren B Guthrie; Guillermo J Tearney; Daniel Irimia; Bryan P Hurley
Journal:  J Cyst Fibros       Date:  2021-02-13       Impact factor: 5.482

7.  Cystic Fibrosis Sputum Impairs the Ability of Neutrophils to Kill Staphylococcus aureus.

Authors:  Kayla Fantone; Samantha L Tucker; Arthur Miller; Ruchi Yadav; Eryn E Bernardy; Rachel Fricker; Arlene A Stecenko; Joanna B Goldberg; Balázs Rada
Journal:  Pathogens       Date:  2021-06-04

Review 8.  Immunomodulation in Cystic Fibrosis: Why and How?

Authors:  Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

9.  Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages.

Authors:  Shuzhong Zhang; Chandra L Shrestha; Benjamin L Wisniewski; Hanh Pham; Xucheng Hou; Wenqing Li; Yizhou Dong; Benjamin T Kopp
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

Review 10.  Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis.

Authors:  Giulio Cabrini; Alessandro Rimessi; Monica Borgatti; Ilaria Lampronti; Alessia Finotti; Paolo Pinton; Roberto Gambari
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.